University of Manchester Techbio Spin-Out Secures £5 Million to Deploy Quantum Physics, AI Modelling, and Highly Automated Labs to Power Next Gen Enzyme Engineering

[#item_full_content]MANCHESTER, England–(BUSINESS WIRE)–Imperagen, a Manchester-based techbio company using AI and quantum physics to engineer better enzymes faster, has closed a £5 million seed funding round led by PXN Ventures with participation from Imperagen’s existing investors IQ Capital and Northern Gritstone. The raise brings Imperagen’s total funding to £8.5 million and will accelerate research and development, expand its wet lab capabilities, and build out its go-to-market function over the next 18 mon